Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Sonnet BioTherapeutics Holdings, Inc. (SONN) had Return on Tangible Equity of 1531.12% for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
$0.02M |
|
$-7.44M |
|
-- |
|
$0.02M |
|
$11.87M |
|
$-11.85M |
|
$4.41M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-7.44M |
|
$-11.85M |
|
$-11.77M |
|
0.66M |
|
0.66M |
|
$-11.35 |
|
$-11.35 |
|
| Balance Sheet Financials | |
$2.12M |
|
$0.02M |
|
$0.65M |
|
$2.77M |
|
$3.21M |
|
-- |
|
$0.05M |
|
$3.26M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
0.65M |
|
| Cash Flow Statement Financials | |
$-8.61M |
|
$-0.01M |
|
$6.49M |
|
$2.27M |
|
$0.15M |
|
$-2.12M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.66 |
|
-- |
|
-- |
|
-- |
|
-0.17 |
|
100.00% |
|
-63617.90% |
|
-63617.90% |
|
-63171.67% |
|
-39929.30% |
|
-39929.30% |
|
$-8.61M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.02 |
|
0.01M |
|
1531.14% |
|
|
Return on Tangible Equity |
1531.12% |
-268.39% |
|
1531.12% |
|
$-0.75 |
|
$-13.14 |
|
$-13.14 |
|